Sodium Fluoride PET/CT for the Evaluation of Skeletal Cancer

Stopped early · Not applicable

Conditions studied: Bone Cancer

In brief

This clinical trial studies fluorine F-18 sodium fluoride positron emission tomography (PET)/computed tomography (CT) in diagnosing bone tumors in patients with cancer. Diagnostic procedures, such as fluorine F-18 sodium fluoride PET/CT, may help find and diagnose bone cancer

Key facts

Study ID

NCT01541358

Run by

Stanford University

People needed

2

Starts

2012-05-01

Expected to finish

2012-09-01

Last updated by the study team

2017-06-14

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients referred for evaluation of suspected skeletal cancer
• Patients must understand and voluntarily sign an informed consent form after the contents have been fully explained to them

You may not qualify if…

• Patients who cannot complete a PET/CT scan
• Pregnant women
• Healthy volunteers

Where it is running

• Stanford University — Stanford, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.